Susan E. Dubé

Susan E. Dubé

Direktor/Vorstandsmitglied bei
La Jolla Playhouse, Inc.
77 Jahre
Health Technology
Consumer Services
Health Services

Profil

Susan E.
Dubé
was the founder of Somaxon Pharmaceuticals, Inc. (2003) as Senior Vice President-Corporate Development.
Ms. Dubé is also the founder of Sorriso Pharmaceuticals, Inc. Ms. Dubé is currently a Trustee at La Jolla Playhouse, Inc. Former positions include Chief Executive Officer at Biointerventions, Inc., Consultant at Cypress Bioscience, Inc., Chief Operating Officer & Executive Vice President at Cytyc Prenatal Products Corp., SVP-Strategy & Corporate Development at Imagyn Medical Technologies, Inc. (1997-1998), Senior Vice President-Corporate Development at Women First HealthCare, Inc. (1998-2002), Acting Chief Business Officer at BrainCells, Inc., Vice President-Marketing & Corporate Development at Imagyn Medical, Inc., Vice President-Ventures at The Brigham & Women's Hospital, Inc., and VP-Business Development & Administration at Amplyx Pharmaceuticals, Inc. Education includes an MBA from Harvard University and an undergraduate degree from Simmons University.

Aktive Positionen von Susan E. Dubé

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Susan E. Dubé

UnternehmenPositionEnde
Gründer 01.02.2018
Gründer 15.04.2009
Corporate Officer/Principal 01.02.2002
Corporate Officer/Principal 01.06.1998
Verwaltungsdirektor -
Sehen Sie sich die Erfahrung von Susan E. Dubé im Detail an

Ausbildung von Susan E. Dubé

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

64

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Consumer Services

Commercial Services

Biointerventions, Inc.

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Susan E. Dubé